科学｜iPS細胞による心筋シート初実用化 / Science | First Practical Application of Cardiac Sheets Using iPS Cells

Summary

On September 29, 2023, a cardiac sheet made from iPS cells, called “Reheart,” was transplanted for the first time into a patient with heart failure at a hospital in Osaka.

This transplant marks a significant milestone, occurring 20 years after Professor Shinya Yamanaka at Kyoto University first created iPS cells in 2006, and it represents the first clinical application of this technology in the world. The physician expressed a hope that “as many suffering individuals as possible can be helped,” and this procedure is seen as a promising new step in regenerative medicine.

Dialogue

This dialogue is fictional and based on the article.

Chako: Hey Log, I heard that iPS cells are used to create cardiac sheets! Isn’t that amazing?
Log: It really is. The fact that cardiac sheets made from iPS cells, called “Reheart,” have actually been transplanted is a significant milestone in medical advancement.
Chako: It could help save patients with heart failure!
Log: Exactly. This is expected to increase treatment options for severe heart diseases.
Navi: The progress in regenerative medicine using iPS cells is also believed to contribute to reducing medical costs and easing the burden on patients.
Chako: I’m really excited to see how future medicine continues to evolve!

Admin’s Note

The practical application of cardiac sheets using iPS cells is generating high expectations as it could open a new horizon in regenerative medicine. This approach has the potential to overcome challenges that have been difficult to address with existing medical technologies in the treatment of heart failure patients, making future research and its practical implementation a focal point of interest. Additionally, it may lead to reduced medical costs and improved quality of life for patients. I hope that many people will benefit from this technology in the future.